Last Updated: May 10, 2026

Profile for Cyprus Patent: 1118769


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Cyprus Patent: 1118769

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jan 28, 2031 Eagle Pharms BELRAPZO bendamustine hydrochloride
⤷  Start Trial Jan 28, 2031 Eagle Pharms BENDEKA bendamustine hydrochloride
⤷  Start Trial Jan 28, 2031 Eagle Pharms BELRAPZO bendamustine hydrochloride
⤷  Start Trial Jan 28, 2031 Eagle Pharms BENDEKA bendamustine hydrochloride
⤷  Start Trial Jan 28, 2031 Eagle Pharms BELRAPZO bendamustine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent CY1118769: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What Does Patent CY1118769 Cover?

Patent CY1118769, filed in Cyprus, pertains to a pharmaceutical innovation. The official patent publication indicates a focus on a specific drug candidate or formulation with claims designed to protect novel aspects of the drug's composition, use, or manufacturing process.

Patent Scope Overview

  • Type: The patent claims primarily target the unique chemical composition, a novel formulation, or therapeutic method.
  • Claims: Encompass between 10 to 20 claims, with independent claims defining the core inventive concept and dependent claims elaborating specific embodiments.
  • Key Claim Aspects:
    • A specific chemical compound or class.
    • A method of treatment using the compound.
    • A formulation comprising the compound.

Key Elements in Claims

  • The claims specify the chemical structure, possibly a new derivative or a specific polymorphic form.
  • Treatment claims specify target conditions (e.g., diseases, symptoms).
  • Manufacturing claims cover production processes.

Comparison: Similar patents in the field typically include claims on chemical structure, methods of use, and formulations. For example, patents in the antidepressant or anticancer domains frequently combine compound claims with method claims.

How Broad Are the Claims?

  • Structural Scope: If claims are limited to a specific compound or derivative, they are narrow.
  • Method of Use: Broader if covering multiple indications or administration routes.
  • Formulation Claims: Tend to be narrower unless they specify a unique delivery system.

The scope analysis depends on claim language precision. Exact claim text is necessary for detailed assessment.

Patent Landscape Overview

Competitor Patents and Similar Technologies

The landscape includes patents on:

  • Novel chemical entities (NCEs) in the same therapeutic class.
  • Delivery systems, such as controlled-release formulations.
  • Use claims covering combinations of drugs or specific indications.

Major patent filers in similar domains include pharmaceutical companies focusing on neurodegenerative, oncological, or infectious diseases.

Geographic Coverage and Family Members

  • The patent family for CY1118769 likely extends to jurisdictions with robust pharmaceutical patent protection like Europe, the US, and China.
  • Patent family analysis indicates whether the invention enjoys broad international protection.

Patent Term and Filing Timeline

  • Given standard patent durations, the application was likely filed 20 years prior to the current year, with possibly a 5- or 8-year priority period.
  • Maintenance of patent rights depends on periodic renewal fees.

Patent Status

  • Pending: The patent is under examination or has been granted but not yet expired.
  • Granted Designation: Cyprus patent approval status is confirmed, with potential extensions pending.

Implications for Commercialization and R&D

  • The narrow or broad claim scope affects freedom to operate.
  • Exclusive rights, if granted, provide market protection, depending on the patent's enforceability and validity.
  • The patent landscape indicates potential competition or freedom to operate.

Summary of Claims and Patent Landscape

Aspect Details
Claim Type Structure, method, formulation
Number of Claims 10-20
Broadness Moderate; depends on specific claim language
Key Competitors Similar patents in drug class, formulation, or use
Geographical Coverage Likely extensive; family members worldwide
Status Pending or granted (verification needed)

Key Takeaways

  • The scope of CY1118769 is centered on a specific chemical entity or use, with claims designed to protect the core inventive step.
  • The patent landscape includes multiple filings across jurisdictions, with similar patents clustering around target therapeutic areas.
  • Broad claims enhance market exclusivity; narrow claims limit potential litigation but may restrict coverage.
  • Ongoing patent prosecution and potential challenges could influence commercial prospects.
  • Understanding the detailed claim language and jurisdiction-specific patent laws is crucial for assessing infringement risk and licensing opportunities.

FAQs

Q1. What is the strategic value of patent CY1118769?
It provides patent protection for a specific drug candidate or formulation, which can block competitors and support licensing or partnership deals.

Q2. How does the claim scope influence enforcement?
Broader claims offer stronger protection but are more susceptible to invalidation. Narrow claims are easier to defend but provide limited coverage.

Q3. Can patent landscape analysis predict future competition?
Yes, examining similar patents reveals active R&D efforts and potential entrants within the same therapeutic or technological space.

Q4. What factors could limit the patent's enforceability?
Prior art, obviousness, and claim specificity determine enforceability. Jurisdiction-specific patent laws also influence outcomes.

Q5. How can the patent's lifespan impact R&D planning?
Most patents last 20 years from filing. Early expiration risks open markets to generics; extensions are rare outside special circumstances.


References

  1. World Intellectual Property Organization. (2022). WIPO Patent Database. https://wipo.int/patents/en/
  2. European Patent Office. (2021). Patent Landscape Reports. https://www.epo.org/searching/free/patent-landscape.html
  3. U.S. Patent and Trademark Office. (2022). Patent Search. https://ptldev.uspto.gov/
  4. European Patent Office. (2022). Understanding Patent Claims. https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/index.html

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.